1994
DOI: 10.1007/bf00319432
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of secretory granule formation in chronically hypersecretory melanotrophs in the rat pituitary

Abstract: The formation of secretory granules in chronically hypersecretory melanotrophs in the rat pituitary was studied. Hypersecretion was induced by treatment with the dopamine antagonist haloperidol (1.5 mg/kg daily for 7 days), which releases the normal neural dopaminergic inhibition of secretion from the melanotroph. Morphometric analysis showed a 100% increase in the volume fraction of granular endoplasmic reticulum after haloperidol treatment, while the volume fractions of electron-dense granules, electron-luce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…In rat melanotrophs, dopamine regulates secretion by inhibiting adenylyl cyclase activity (391). Bromocriptine, a dopamine D 2 agonist, reduces the size of secretory granules in melanotrophs (20), while haloperidol, a dopamine antagonist, increases the size (21). Thus cAMP might promote hormone secretion by enlarging the size of the secretory granules.…”
Section: B Pituitary Cellsmentioning
confidence: 97%
“…In rat melanotrophs, dopamine regulates secretion by inhibiting adenylyl cyclase activity (391). Bromocriptine, a dopamine D 2 agonist, reduces the size of secretory granules in melanotrophs (20), while haloperidol, a dopamine antagonist, increases the size (21). Thus cAMP might promote hormone secretion by enlarging the size of the secretory granules.…”
Section: B Pituitary Cellsmentioning
confidence: 97%
“…However, an increase of granules was reported in hypersecretory melanotrophs. It could be due to mechanisms operating at an early stage of granule formation (Bäck and Soinila, 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Total RNA was isolated from control neurointermediate lobes (n = 5) and subjected to multiplex RNase protection analysis and quantification with a Phosphorlmager to determine the level of each transcript indicated. After quantification, the molecules of mRNA/cell were calculated using a yield of 5 ig RNA per neurointermediate lobe and published values of 3 x iOmelanotropes/adult male rat neurointermediate lobe (Mains et al, 1987;Back, 1989;Back and Soinila, 1994 opposite effect on levels of each of these transcripts. It is interesting that the data demonstrate coordinate regulation of peptide precursor and some, but not a!…”
Section: Transcript Levels Begin To Change Within a Day Of Drug Treatmentioning
confidence: 99%
“…4, POMC transcripts were '-.~200-fo!dmore prevalent than PC2 and CPH transcripts, and 1,000-fold more prevalent than PAM, PC1, or Cytb561 transcripts. Using our observed recovery of 5 ,ug total RNA per neurointermediate lobe and the literature values for the number of melanotropes per neurointermediate lobe (Mains et al, 1987;Back, 1989;Back and Soinila, 1994), we determined the number of molecules of mRNA/me!anotrope. The number of POMC transcripts per cell is estimated to be 31,000, with less prevalent transcripts such as PC 1 and PAM present in the range of 20-30 mRNA molecules per melanotrope.…”
Section: Transcript Levels Begin To Change Within a Day Of Drug Treatmentioning
confidence: 99%